Epigenetic Upregulation of H19 and AMPK Inhibition Concurrently Contribute to S-Adenosylhomocysteine Hydrolase Deficiency-Promoted Atherosclerotic Calcification

Circ Res. 2022 May 13;130(10):1565-1582. doi: 10.1161/CIRCRESAHA.121.320251. Epub 2022 Apr 12.

Abstract

Background: S-adenosylhomocysteine (SAH) is a risk factor of cardiovascular disease; inhibition of SAH hydrolase (SAHH) results in SAH accumulation and induces endothelial dysfunction and atherosclerosis. However, the effect and mechanism of SAHH in atherosclerotic calcification is still unclear. We aimed to explore the role and mechanism of SAHH in atherosclerotic calcification.

Methods: The relationship between SAHH and atherosclerotic calcification was investigated in patients with coronary atherosclerotic calcification. Different in vivo genetic models were used to examine the effect of SAHH deficiency on atherosclerotic calcification. Human aortic and murine vascular smooth muscle cells (VSMCs) were cultured to explore the underlying mechanism of SAHH on osteoblastic differentiation of VSMCs.

Results: The expression and activity of SAHH were decreased in calcified human coronary arteries and inversely associated with coronary atherosclerotic calcification severity, whereas plasma SAH and total homocysteine levels were positively associated with coronary atherosclerotic calcification severity. Heterozygote knockout of SAHH promoted atherosclerotic calcification. Specifically, VSMC-deficient but not endothelial cell-deficient or macrophage-deficient SAHH promoted atherosclerotic calcification. Mechanistically, SAHH deficiency accumulated SAH levels and induced H19-mediated Runx2 (runt-related transcription factor 2)-dependent osteoblastic differentiation of VSMCs by inhibiting DNMT3b (DNA methyltransferase 3b) and leading to hypomethylation of the H19 promoter. On the contrary, SAHH deficiency resulted in lower intracellular levels of adenosine and reduced AMPK (AMP-activated protein kinase) activation. Adenosine supplementation activated AMPK and abolished SAHH deficiency-induced expression of H19 and Runx2 and osteoblastic differentiation of VSMCs. Finally, AMPK activation by adenosine inhibited H19 expression by inducing Sirt1 (sirtuin-1)-mediated histone H3 hypoacetylation and DNMT3b-mediated hypermethylation of the H19 promoter in SAHH deficiency VSMCs.

Conclusions: We have confirmed a novel correlation between SAHH deficiency and atherosclerotic calcification and clarified a new mechanism that epigenetic upregulation of H19 and AMPK inhibition concurrently contribute to SAHH deficiency-promoted Runx2-dependent atherosclerotic calcification.

Keywords: S-adenosylhomocysteine; epigenomics; histones; humans; mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Adenosine / metabolism
  • Amino Acid Metabolism, Inborn Errors
  • Animals
  • Atherosclerosis* / metabolism
  • Calcinosis* / genetics
  • Cells, Cultured
  • Core Binding Factor Alpha 1 Subunit / genetics
  • Epigenesis, Genetic
  • Glycine N-Methyltransferase / deficiency
  • Humans
  • Mice
  • Myocytes, Smooth Muscle / metabolism
  • RNA, Long Noncoding
  • S-Adenosylhomocysteine / metabolism
  • Up-Regulation
  • Vascular Calcification* / genetics
  • Vascular Calcification* / metabolism

Substances

  • Core Binding Factor Alpha 1 Subunit
  • H19 long non-coding RNA
  • RNA, Long Noncoding
  • RUNX2 protein, human
  • S-Adenosylhomocysteine
  • Glycine N-Methyltransferase
  • AMP-Activated Protein Kinases
  • Adenosine

Supplementary concepts

  • Hypermethioninemia